{"id":58691,"date":"2023-05-04T10:30:00","date_gmt":"2023-05-04T08:30:00","guid":{"rendered":"https:\/\/www.embl.org\/news\/?p=58691"},"modified":"2025-12-18T11:18:09","modified_gmt":"2025-12-18T10:18:09","slug":"vizgen-joins-embl-science-industry-programme","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/","title":{"rendered":"Vizgen joins EMBL science-industry programme"},"content":{"rendered":"\n<p><a href=\"http:\/\/www.vizgen.com\/\">Vizgen<\/a>, the life science company dedicated to improving human health by visualising single-cell spatial genomics information, has joined EMBL\u2019s Corporate Partnership Programme (CPP).<\/p>\n\n\n\n<p>CPP members benefit from direct connection with EMBL\u2019s world-leading molecular biology and technology development, and their support enables EMBL to provide additional training opportunities for the next generation of molecular life scientists.<\/p>\n\n\n\n<p>&#8220;We look forward to the ways in which our scientists and Vizgen&#8217;s can share ideas and technology for this promising field of spatially resolved genomics to ultimately advance our understanding of biology acting <em>in situ<\/em>.&#8221; said Vladimir Benes, head of EMBL\u2019s Genomics Core Facility. \u201cTogether with Vizgen, we will pursue various educational, methodological, and career development activities.&#8221;<\/p>\n\n\n\n<p>\u201cVizgen is proud to join EMBL\u2019s Corporate Partnership Programme,\u201d said Terry Lo, Vizgen President and CEO. \u201cWe look forward to working alongside the organisation to further the development and global reach of the spatial genomics industry.\u201d<\/p>\n\n\n\n<p>CPP members support EMBL\u2019s scientific training and conferences programme, as well as the scientific visitor programme, with CPP fellowships to enable attendance and by participating in discussions of future conference topics and practical courses.&nbsp;<\/p>\n\n\n\n<p>\u201cWith Vizgen\u2019s support, EMBL can extend access to our world-class scientific gatherings to scientists who otherwise might not be able to participate,\u201d said Nadine Ilk, CPP manager. \u201cThis gives these scientists the opportunity to contribute to and participate in advanced scientific training.\u201d&nbsp;<\/p>\n\n\n\n<p>Ilk emphasised that the CPP was designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.&nbsp;<\/p>\n\n\n\n<p>Members also access tailored opportunities to engage with EMBL\u2019s outstanding research and core facilities faculty.<\/p>\n\n\n\n<p><strong>About Vizgen<\/strong><\/p>\n\n\n\n<p>Vizgen Inc. is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single-cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context. The company\u2019s MERSCOPE\u00ae Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivalled detection efficiency at subcellular resolution. MERSCOPE\u00ae provides transformative insight into a wide range of tissue-scale basic research and translational medicine in oncology, immunology, neuroscience, infectious disease, developmental biology, cell and gene therapy, and is an essential tool for accelerating drug discovery and development. For more information, go to <a href=\"http:\/\/www.vizgen.com\">www.vizgen.com<\/a> or connect on social media Twitter, LinkedIn and Facebook.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vizgen, the life science company dedicated to improving human health by visualising single-cell spatial genomics information, has joined EMBL\u2019s Corporate Partnership Programme.<\/p>\n","protected":false},"author":100,"featured_media":58711,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17595,3],"tags":[172,71,13987,13072,238],"embl_taxonomy":[19535,5802,13697],"class_list":["post-58691","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-connections","category-lab-matters","tag-corporate-partnership-programme","tag-industry","tag-innovation","tag-support-embl","tag-technology-transfer","embl_taxonomy-corporate-partnership-programme","embl_taxonomy-support-embl","embl_taxonomy-technology-transfer"],"acf":{"featured":true,"show_featured_image":false,"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"article_intro":"<p>US-based spatial genomics firm joins as corporate-level supporter<\/p>\n","related_links":[{"link_description":"Vizgen","link_url":"https:\/\/vizgen.com\/"},{"link_description":"EMBL Corporate Partnership Programme","link_url":"https:\/\/www.embl.org\/about\/info\/support\/embl-corporate-partnership-programme\/"}],"source_article":false,"in_this_article":false,"press_contact":"None","article_translations":false,"languages":"","vf_locked":false,"vfwp-news_embl_taxonomy":[5802,13697,19535]},"embl_taxonomy_terms":[{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";i:2;s:36:\"0d3270ca-455c-428a-86f4-c61b1de8c3e0\";}","parents":[],"name":["Corporate Partnership Programme"],"slug":"corporate-partnership-programme","description":"What &gt; Support EMBL &gt; Corporate Partnership Programme"},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"bc1eaadd-1f50-4140-8e9b-e58fc33a39fc\";i:2;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";}","parents":[],"name":["Support EMBL"],"slug":"support-embl","description":"What &gt; About EMBL &gt; Support EMBL"},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"7b2a9600-c96d-48ee-8c47-13acdad7592d\";i:2;s:36:\"d5e286b4-5988-4b10-a9b5-732c5073b307\";}","parents":[],"name":["Technology Transfer "],"slug":"technology-transfer","description":"What &gt; Industry relations &gt; Technology Transfer"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vizgen joins EMBL science-industry programme | EMBL<\/title>\n<meta name=\"description\" content=\"Vizgen, which applies single-cell spatial genomics to improve human health, has joined EMBL\u2019s Corporate Partnership Programme.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vizgen joins EMBL science-industry programme | EMBL\" \/>\n<meta property=\"og:description\" content=\"Vizgen, which applies single-cell spatial genomics to improve human health, has joined EMBL\u2019s Corporate Partnership Programme.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T08:30:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-18T10:18:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ivy Kupec\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ivy Kupec\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/\"},\"author\":{\"name\":\"Ivy Kupec\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274\"},\"headline\":\"Vizgen joins EMBL science-industry programme\",\"datePublished\":\"2023-05-04T08:30:00+00:00\",\"dateModified\":\"2025-12-18T10:18:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/\"},\"wordCount\":407,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg\",\"keywords\":[\"corporate partnership programme\",\"industry\",\"innovation\",\"support embl\",\"technology transfer\"],\"articleSection\":[\"Connections\",\"Lab Matters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/\",\"name\":\"Vizgen joins EMBL science-industry programme | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg\",\"datePublished\":\"2023-05-04T08:30:00+00:00\",\"dateModified\":\"2025-12-18T10:18:09+00:00\",\"description\":\"Vizgen, which applies single-cell spatial genomics to improve human health, has joined EMBL\u2019s Corporate Partnership Programme.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg\",\"width\":1000,\"height\":600,\"caption\":\"Dries Van Hemelen from Vizgen visited EMBL in April to finalise details for joining EMBL\u2019s Corporate Partnership Programme. Credit: Stuart Ingham\/EMBL\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274\",\"name\":\"Ivy Kupec\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g\",\"caption\":\"Ivy Kupec\"},\"url\":\"https:\/\/www.embl.org\/news\/author\/ivy-kupecembl-de\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vizgen joins EMBL science-industry programme | EMBL","description":"Vizgen, which applies single-cell spatial genomics to improve human health, has joined EMBL\u2019s Corporate Partnership Programme.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/","og_locale":"en_US","og_type":"article","og_title":"Vizgen joins EMBL science-industry programme | EMBL","og_description":"Vizgen, which applies single-cell spatial genomics to improve human health, has joined EMBL\u2019s Corporate Partnership Programme.","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2023-05-04T08:30:00+00:00","article_modified_time":"2025-12-18T10:18:09+00:00","og_image":[{"width":1000,"height":600,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg","type":"image\/jpeg"}],"author":"Ivy Kupec","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Ivy Kupec","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/"},"author":{"name":"Ivy Kupec","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274"},"headline":"Vizgen joins EMBL science-industry programme","datePublished":"2023-05-04T08:30:00+00:00","dateModified":"2025-12-18T10:18:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/"},"wordCount":407,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg","keywords":["corporate partnership programme","industry","innovation","support embl","technology transfer"],"articleSection":["Connections","Lab Matters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/","name":"Vizgen joins EMBL science-industry programme | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg","datePublished":"2023-05-04T08:30:00+00:00","dateModified":"2025-12-18T10:18:09+00:00","description":"Vizgen, which applies single-cell spatial genomics to improve human health, has joined EMBL\u2019s Corporate Partnership Programme.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/vizgen-joins-embl-science-industry-programme\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg","width":1000,"height":600,"caption":"Dries Van Hemelen from Vizgen visited EMBL in April to finalise details for joining EMBL\u2019s Corporate Partnership Programme. Credit: Stuart Ingham\/EMBL"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274","name":"Ivy Kupec","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g","caption":"Ivy Kupec"},"url":"https:\/\/www.embl.org\/news\/author\/ivy-kupecembl-de\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/05\/20230428_Vizgen_newCPP_partner-wp.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/58691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/100"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=58691"}],"version-history":[{"count":5,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/58691\/revisions"}],"predecessor-version":[{"id":77291,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/58691\/revisions\/77291"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/58711"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=58691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=58691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=58691"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=58691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}